fluocinonide has been researched along with tacrolimus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kamijima, M; Miyake, M; Ohshima, M; Sakamoto, T; Takeda, M | 1 |
Grainge, MJ; Jayasekera, P; Jessop, S; Whitelaw, DA | 1 |
Al-Hadlaq, M; Bajonaid, A; Chirravur, P; Hussein, M; Intini, R; Klein, BA; Sandhu, S; Sonis, S; Sroussi, H; Treister, N; Vacharotayangul, P; Xu, Y | 1 |
2 review(s) available for fluocinonide and tacrolimus
Article | Year |
---|---|
Drugs for discoid lupus erythematosus.
Topics: Acitretin; Albuterol; Calcineurin Inhibitors; Dermatologic Agents; Fluocinonide; Humans; Hydrocortisone; Hydroxychloroquine; Lupus Erythematosus, Discoid; Randomized Controlled Trials as Topic; Tacrolimus; Treatment Outcome | 2017 |
Oral lichen planus: comparative efficacy and treatment costs-a systematic review.
Topics: Administration, Topical; Calcineurin Inhibitors; Clobetasol; Cyclosporins; Dexamethasone; Fluocinonide; Health Care Costs; Humans; Lichen Planus, Oral; Steroids; Tacrolimus; Treatment Outcome; Triamcinolone | 2022 |
1 other study(ies) available for fluocinonide and tacrolimus
Article | Year |
---|---|
Staphylococcal enterotoxin B causes proliferation of sensory C-fibers and subsequent enhancement of neurogenic inflammation in rat skin.
Topics: Animals; Anti-Inflammatory Agents; Brain-Derived Neurotrophic Factor; Capillary Permeability; Disease Models, Animal; Enterotoxins; Fluocinonide; Fluorescent Antibody Technique; Immunosuppressive Agents; Male; Nerve Fibers, Unmyelinated; Nerve Growth Factor; Neurogenic Inflammation; Rats; Receptors, Neurokinin-1; Skin; Specific Pathogen-Free Organisms; Substance P; Tacrolimus; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2011 |